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Abstract: Schaf-assoziiertes bösartiges Katarrhalfieber (BKF) ist eine sporadisch auftretende Erkrankung
von Rindern, anderen Wiederkäuern und Schweinen. Die Erkrankung führt in der Regel zum Tod des
betroffenen Tieres. Der Erreger der europäischen Form des bösartigen Katarrhalfieber ist das Ovine Her-
pesvirus 2 (OvHV-2). Ein System zur Vermehrung von OvHV-2 in vitro konnte bislang nicht etabliert
werden. Immunologische Methoden für die Identifikation viraler Proteine sind unzureichend. Aus diesen
Gründen weiss man nur wenig über die Pathogenese der OvHV-2 Infektion. Wir haben virale DNA
in Cosmide kloniert und die Nukleotid-Sequenzen analysiert. Dabei konnten wir zwei offene Leseraster
(Open Reading Frames, ORF) identifizieren, die mit grosser Wahrscheinlichkeit für Strukturproteine von
OvHV-2 kodieren. ORF43 ist verwandt mit Herpes Simplex Virus 1 (HSV-1) UL6, das für ein Kapsid-
protein kodiert, welches eine wichtige Rolle bei der Verpackung viraler DNA spielt. ORF63 ist verwandt
mit UL37 von HSV-1 und HSV-2 und somit mit Tegumentproteinen dieser Viren. Ausgewählte Epi-
tope dieser Proteine wurden als Glutathion-S- Transferase (GST) Fusionsproteine exprimiert und zur
Herstellung von Antiseren für die Immunhistochemie verwendet. Mit Hilfe dieser Seren war es möglich
produktiv mit OvHV-2 infizierte Zellen im Appendix experimentell infizierter Kaninchen zu markieren.
Die infizierten Zellen konnten als M-Zellen sowie epitheliale Zellen identifiziert werden. M-Zellen in-
teragieren intensiv mit Lymphozyten, die das Genom von OvHV-2 enthalten können. Wir vermuten,
dass diese Interaktion zu lokaler Reaktivierung von latentem OvHV-2 führt und es in der Folge zum
produktiven Zyklus in epithelialen Zellen kommt. Es war uns somit möglich mit Hilfe von Antiseren,
die gegen Strukturproteine von OvHV-2 gerichtet sind eine Verbindung zwischen klonierter viraler DNA
und Antigen in Gewebe von infizierten Tieren herzustellen. Ausserdem konnten neue Aspekte bezüglich
der Pathogenese von BKF aufgezeigt werden. Sheep-associated malignant catarrhal fever (MCF), caused
by the Ovine herpesvirus 2 (OvHV-2), is a sporadic and usually fatal infectious disease of cattle, other
ruminant species, and swine. A system for propagation of OvHV-2 in vitro has not yet been identified
and immunological tools for the identification of viral proteins are scarce. Therefore, the pathogenesis of
OvHV-2 infection is poorly understood. We have determined nucleotide sequences from cosmid-cloned
viral DNA and identified two open reading frames, which were likely to encode for structural OvHV-2
proteins. ORF43 is related to UL6 of herpes simplex virus 1 (HSV-1), which encodes the pore forming
capsid protein, required for packaging of viral DNA. ORF63, encoding a putative tegument protein, is
related to UL37 of HSV-1 and HSV-2. GST-fusion proteins containing antigenic regions of these predicted
proteins were generated and used to raise antisera for immunohistology. Using these sera, productively
OvHV-2-infected cells were detected in gut tissue of experimentally infected rabbits. They were identified
as M-cells and adjacent epithelial cells in the appendix. Since M-cells interact closely with lymphocytes,
which may harbor the OvHV-2 genome, we hypothesize that such interactions lead to local reactivation
of OvHV-2 from latency, which then causes productive infection of epithelial cells in the vicinity. Thus,
antisera raised against two predicted structural proteins of OvHV-2 were able to establish a link between
cloned viral DNA and antigens present in tissues of diseased animals. Furthermore, the results reveal
new aspects regarding the pathogenesis of MCF.
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Abstract 
Sheep-associated malignant catarrhal fever (MCF), caused by the Ovine 
herpesvirus 2 (OvHV-2), is a sporadic and usually fatal infectious disease of 
cattle, other ruminant species, and swine. A system for propagation of OvHV-2 
in vitro has not yet been identified and immunological tools for the identification 
of viral proteins are scarce. Therefore, the pathogenesis of OvHV-2 infection is 
poorly understood.  
We have determined nucleotide sequences from cosmid-cloned viral DNA and 
identified two open reading frames, which were likely to encode for structural 
OvHV-2 proteins. ORF43 is related to UL6 of herpes simplex virus 1 (HSV-1), 
which encodes the pore forming capsid protein, required for packaging of viral 
DNA. ORF63, encoding a putative tegument protein, is related to UL37 of HSV-
1 and HSV-2. GST-fusion proteins containing antigenic regions of these 
predicted proteins were generated and used to raise antisera for 
immunohistology.  
Using these sera, productively OvHV-2-infected cells were detected in gut tissue 
of experimentally infected rabbits. They were identified as M-cells and adjacent 
epithelial cells in the appendix. Since M-cells interact closely with lymphocytes, 
which may harbor the OvHV-2 genome, we hypothesize that such interactions 
lead to local reactivation of OvHV-2 from latency, which then causes productive 
infection of epithelial cells in the vicinity. Thus, antisera raised against two 
predicted structural proteins of OvHV-2 were able to establish a link between 
cloned viral DNA and antigens present in tissues of diseased animals. 
Furthermore, the results reveal new aspects regarding the pathogenesis of MCF. 
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Introduction 
Malignant catarrhal fever (MCF) is a sporadic and usually fatal infectious 
disease of cattle, other ruminant species, and swine (1,7,19,23,24,25). Major 
clinical symptoms include nasal and ocular discharge, conjunctivitis, 
gastroenteritis, hematuria, and fever (25).  
There are two etiologically distinct forms of MCF: (i) a wildebeest-associated 
form, caused by alcelaphine herpesvirus 1 (AlHV-1), and (ii) a sheep-associated 
form (SA-MCF), occurring worldwide and implicated with Ovine herpesvirus 2 
(OvHV-2). AlHV-1 was isolated a number of years ago and can be propagated 
in cell culture (6,28,31). Following this, the entire genomic sequence of AlHV-1 
was determined relatively easily (13). Accordingly, AlHV-1 is a member of the 
genus Rhadinovirus within the subfamily Gammaherpesvirinae. In contrast, no 
system for propagation of OvHV-2 in vitro has yet been identified (7) and the 
sequencing of its genome is still incomplete. Its taxonomical status is not secure, 
although it has been designated as a gammaherpesvirus on the basis of DNA 
homology to AlHV-1 (5).  
Both AlHV-1 and OvHV-2 are asymptomatic in their natural hosts, i.e. 
wildebeest and sheep (6,19). However, natural or experimental infection of other 
ungulates or swine as well as rabbits and hamsters may lead to a fatal 
lymphoproliferative disease during which viral DNA can be detected and 
quantified in white blood cells as well as in proliferating lymphocytes within 
affected organs (1,3,19,20,29,30,37). Yet, there is very little evidence of 
productive viral replication in the same cells (7,32). Thus, it appears as if 
OvHV-2 would initially favor the establishment of latency, not initiation of the 
lytic cycle. While this is not uncommon for gamma herpesviruses, these 
circumstances make it very difficult to develop specific immunological tools for 
the identification of lytically infected cells. Although there is a monoclonal 
antibody against AlHV-1, which binds to a shared epitope of AlHV-1 and 
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OvHV-2 (22), monospecific antisera or monoclonal antibodies against OvHV-2 
have not yet been raised. Thus, the study of the contribution of replicating virus 
to the pathogenesis of OvHV-2 within the infected host has made but little 
progress.  
To overcome these difficulties, a cosmid library was constructed from an 
OvHV-2 infected cattle cell line that contained mainly circular virus genomes 
(29,32) and viral DNA sequences were determined (J. Rosbottom, G. 
Jayawardane, J. Stewart, H. Reid, and M. Ackermann, manuscript in 
preparation). Two open reading frames (ORFs) were identified, which revealed 
sequence homology to structural proteins of other herpesviruses. The homolog 
to OvHV-2 ORF43 has been reported to encode a minor capsid protein in AlHV-
1 (13) and corresponds to UL6 of herpes simplex virus 1 (HSV-1)(26). ORF63 
matches to the gene for a phosphoprotein of AlHV-1, which is incorporated into 
the tegument and which is related to the gamma 1 gene UL37 of HSV-1 and 
HSV-2 (11,36,48). In order to generate antisera, glutathione S-transferase (GST) 
fusion proteins, containing antigenic parts of these proteins, were generated in E. 
coli and used for the immunization of rabbits and mice. The difficulty in the 
present setting was that a cell culture-adapted strain of OvHV-2 was not 
available for screening of the newly generated antisera. Therefore, the entire 
OvHV-2 ORFs were cloned independently into HSV-1-based amplicon vectors 
to be expressed in eukaryotic cells, either alone or as fusion proteins with 
enhanced green fluorescent protein (eGFP)(38).  
HSV-1 amplicons are virus particles, which contain packaged foreign DNA in 
the place of the viral DNA (42). They are produced by cotransfecting the HSV-1 
genome, deleted for the packaging signals, together with plasmid cloned DNA, 
containing the gene of interest as well as the HSV-1 origin of DNA replication 
and the HSV-1 packaging signal (34). These amplicon particles can then be used 
to transduce susceptible eukaryotic cells. Transduction leads to the expression of 
the foreign genes in these cells and the amounts of gene expression can be 
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controlled by using a promoter of choice (38,47). Successful gene expression 
can be monitored directly under the fluorescent microscope, provided that the 
genes of interest had been fused to sequences encoding for the eGFP. This 
approach represents, therefore, an alternative to the generation of stably 
transformed cell lines, which may or may not express the desired antigens (43). 
Pseudo-tissues can then be prepared from a mixture of transduced and non-
tranduced cells and treated as if they were infected tissues obtained from 
animals. This allows setting of the conditions for the unknown antisera that are 
required for the detection of productively infected cells from animals.  
Here we report on the production of antisera against the proteins encoded by 
ORF43 and ORF63 of OvHV-2. These sera were used for detection of OvHV-2 
lytic antigens in experimentally infected rabbits (30). Productively OvHV-2 
infected cells were detected in the appendix of such animals. These cells were 
further identified as epithelial cells and M-cells. Because M-cells play a role in 
the orchestration of the host's immune response, these findings may be relevant 
for the understanding of the pathogenesis of MCF in susceptible hosts. 
Furthermore, knowledge of these findings may be important for the study of the 
pathogenesis of other gamma herpesviruses. 
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Materials and methods 
Viruses and cells 
Cell-associated infectious OvHV-2 (32) was derived from T cells isolated from a 
cow that subsequently succumbed to SA-MCF in 1994 (BJ1035, from frozen 
stock) and from the first passage of the same isolate in rabbits.  
The HSV-1-based helpervirus-free amplicon sytem, consisting of BAC-cloned 
HSV-1-DNA without packaging signal (pHSVDpacDpacID27Dkn; kindly 
provided by Dr. C. Fraefel) and cloned amplicon DNA (42), was used for the 
eukaryotic expression of OvHV-2 ORF's as described previously (15,33,34). 
Modified Vero 2-2 cells (kindly provided by Dr. R. Sandri-Goldin) (41), needed 
for packaging of amplicon particles, were cultured in Dulbecco’s modified 
Eagle’s medium (DMEM) supplemented with 10% fetal calf serum (FCS), 100 
U/ml penicillin and 100 µg/ml streptomycin and incubated in 5% CO2 at 37°C. 
 
Cosmid cloning, sequencing, and sequence interpretation 
The DNA sequences of ORF43 and ORF63 were obtained as part of a larger 
project to sequence the entire viral genome (J. Rosbottom, G. Jayawardane, J. 
Stewart, H. Reid, and M. Ackermann, manuscript in preparation). Briefly, a 
cosmid library containing the OvHV-2 genome was made in Supercos 1 
(Stratagene, Amsterdam, The Netherlands) essentially as described previously 
(8) and using total cellular DNA from an OvHV-2-positive cell line (BJ1035; 
(32)). An initial OvHV-2-positive cosmid clone was isolated from this library 
using a probe derived from the sequence of part of the ORF75 gene (5). Other 
cosmid clones were then isolated by walking using probes derived from the 
cosmid ends. Cosmid-cloned OvHV-2 DNA was subcloned in an M13 shotgun 
library and subclones were sequenced with BIG-dye terminator version 1.0 
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(Applied Biosystems, Rotkreuz, Switzerland) and analyzed on a MegaBace 1000 
sequencer (Amersham Pharmacia, Biotech, Dübendorf, Switzerland). Computer 
assembly was done with the DNAstar software version 5.05. The redundancy of 
sequencing was 7. Open reading frames were determined using the NCBI ORF 
finder (http://www.ncbi.nlm.nih.gov/gorf/orfig.cgi) and compared with other 
herpesvirus genes using the NCBI BLAST programme 
(http://www.ncbi.nlm.nih.gov/BLAST/). The sequences of ORF43 and ORF63 
have been submitted to Genbank and assigned the accession numbers AY366191 
and AY366192 respectively. Phylogenetic trees were built using MegAlign 
(DNAstar software 5.05) using the Clustal W algorithm with default settings 
(45). 
 
PCR amplification 
DNA sequences encoding for the ORF43 region H284-N435 and the ORF63 
region N833-L944 were amplified from cosmid C33-63 using primers 
containing EcoRI sites for cloning of the products into the pGEX-6P-1 vector 
(Table 1). 
The entire coding sequences of ORF43 and ORF63 were amplified from the 
same cosmid but using primers containing BamHI (ORF43) and EcoRI sites 
(ORF63) for cloning into a HSV-1-based amplicon vector (pHSVPrPUC, kindly 
provided by Dr. Howard Federoff). The coding sequence without stop codon of 
the enhanced green fluorescence protein (eGFP) was amplified from the pGFP-
N3 vector (Clontech, Basel, Switzerland), using primers to generate XbaI sites 
(Table 1). 
For PCR, 5 ml template (0.4 mg / ml C33-63 or 1.5 mg / ml pGFP-N3) was mixed 
with 10 µM of each primer (2 ml), 3 ml Pfu buffer (Stratagene, Amsterdam, The 
Netherlands), 1 ml Pfu polymerase (2.5 U / ml) (Stratagene), 1 ml dNTP (10 mM, 
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Amersham Pharmacia, Biotech, Dübendorf, Switzerland), and 16 ml of sterile 
distilled water. 
Following initial denaturation at 95°C for 1 min, 35 cycles were completed with 
denaturation at 95°C for 1 min, annealing for 1 min at the temperature specified 
for each product in Table 1, and extension at 74°C for the time specified in 
Table 1. All PCR products were analyzed by agarose gel electrophoresis and 
digested with the appropriate enzyme for cloning.  
 
Table 1. Primers for amplification of OvHV-2 DNA and eGFP. 
Oligonucleotidea Sequence (5’-3’)b Annealing (°C)/ 
Extension (min.) 
Product 
length 
fragment 43F GATATCGAATTCCACCTAGATGAGTGTAGTc  50 / 1 478 bp 
fragment 43R TAGAGAATTCCTAGTTAACCTGGTTGGATc    
fragment 63F CTCCGAATTCAATCCCCAAATTTTCCTTGCc  52 / 1 356 bp 
fragment 63R ACGCGAATTCTTACAGCTCCTGCGTAGGCTc    
43F GTCGGATCCAGGATAAAGCTCTTAGGTATGd  60 / 2.5 1735 bp 
43R AGCGGATCCCGGGGCCCGCTACTCAGTCGd    
63F CCTCTCTGGAATTCATGATGGAGAACAAGCd  55 / 4.5 2886 bp 
63R TGGAATTCGGCTGTGAGGCCATGGCGCTACGd    
GFP-F GACGGTACCTCTAGACCGGGATCCATCGCCACCe  55 / 1 763 bp 
GFP-R GCGGCCTCTAGACTTGTACAGCTCGTCCATe   
aF: forward primer, R: reverse primer 
bRestriction sites underscored: cEcoRI, dBamHI, eXbaI 
 
Construction and expression of GST-fusion proteins 
The ampicillin resistant pGEX-6P-1 vector (Amersham Pharmacia Biotech, 
Uppsala, Sweden), designed for isopropyl b-D-thiogalactoside (IPTG) inducible 
expression of glutathione S-transferase (GST) fusion proteins in E. coli, was 
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used. A multiple cloning site (MCS) downstream of the GST-gene and the 
adjoining site for cleavage with human rhinovirus 3C protease allows insertion 
of DNA sequences encoding for the antigenic region of choice. The regions of 
choice were amplified by PCR as described above and inserted into the EcoRI 
locus of the MCS. These plasmids were maintained in E. coli DH5a. 
E. coli BL21 (Amersham Pharmacia Biotech, Dübendorf, Switzerland) were 
used for expression of protein according to the protocols of the manufacturer. 
Briefly, 400 ml LB medium (Chemie Brunschwig AG, Basel, Switzerland) 
containing 100 µg/ml Ampicillin were inoculated at 37°C with 4 ml overnight 
culture. At OD550 = 0.5-0.7, protein expression was induced by adding IPTG 
(Qbiogene, Illkirch Cedex, France) to a final concentration of 1 mM and the 
temperature was reduced to 30°C. After 4 hours bacteria were harvested by 
centrifugation at 3000 x g, 4°C, 10 minutes in a GSA rotor. The cell pellet was 
suspended in 20 ml STE buffer (50 mM NaCl, 50 mM Tris base pH 8.0, 5 mM 
EDTA). Each 200 ml protease-inhibitor (Protease Inhibitor Cocktail, containing 
AEBSF, EDTA, Bestatin, Pepstatin A and E64, Sigma, Buchs, Switzerland) and 
200 ml lysozyme (100 mg/ml) were added. After incubation on ice for 15 
minutes 200 ml 1M DTT and 2 ml 10% sarcosyl were added and the sample 
sonicated for 1 minute. Debris was removed by centrifugation. 4 ml Triton X-
100 (10%) and STE-buffer was added to a final volume of 40 ml. After 
incubation at room temperature for 30 minutes, 500 ml bed volume of prepared 
glutathione sepharose (Amersham Pharmacia Biotech, Dübendorf, Switzerland) 
in phosphate buffered saline (PBS-A, containing 0.14 M NaCl, 2.7 mM KCl, 1.4 
mM KH2PO4, 8.1 mM Na2HPO4) was added and the sample incubated at 4°C for 
4 hours. The beads were harvested by centrifugation at 1800 x g for 10 minutes. 
After 3 times washing with PBS-A, protein was eluted from the beads by the 
addition of 3 times 0.5 ml 10 mM glutathione elution buffer (Amersham 
Pharmacia Biotech, Dübendorf, Switzerland). The protein concentrations were 
determined in a GeneQuant II Spectrophotometer (Amersham Pharmacia 
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Biotech, Dübendorf, Switzerland) at 280 nm, based on the predicted molecular 
weights and calculated molar extinction coefficients (18). The eluates were 
stored at 4°C until further use. 
 
Construction and packaging of amplicon vectors 
The plasmid pHSVPrPUC (kindly provided by Dr. C. Fraefel) used as amplicon 
vector contains the HSV-1 immediate early (IE) 4/5 promoter, followed by an 
MCS for the insertion of a cassette containing the gene of interest, the origin of 
DNA replication (oriS) from HSV-1, and the HSV-1 packaging signal. Among 
other sites, the MCS containes an XbaI site upstream of the BamHI and the 
EcoRI site. The OvHV-2 full length ORFs 43 and 63 were amplified by PCR as 
described above and cloned into the MCS of pHSVPrPUC, using the BamHI 
locus for ORF43 and the EcoRI locus for ORF63 (Table 2). In addition, both 
ORFs were tagged to generate N-terminal eGFP-fusion proteins. For this, the 
eGFP gene was amplified by PCR and cloned into the XbaI site within the MCS 
of the recombinant vectors pHSVPrPUC-43 and pHSVPrPUC-63 in frame with 
either ORF43 or ORF63 (Table 2). 
For packaging, 1.2 x 106 Vero 2-2 cells, seeded in Petri dishes (diameter of 6 
cm), were cotransfected with 250 ml Optimem (Invitrogen, Basel, Switzerland) 
mixed with 0.5 mg Amplicon-plasmid (pHSVPrPUC-GFP-43 0.5 mg/ml, 
pHSVPrPUC-GFP-63 0.58 mg/ml), 0.2 mg pEBHICP27 (0.65 mg/ml) and 2.0 mg 
pHSVDpacDpacID27Dkn (0.435 mg/ml). To this mixture 250 ml Optimem 
containing 16.8 ml Lipofectamin (Invitrogen, Basel, Switzerland) was added. 
After incubation at room temperature for 45 minutes 0.9 ml Optimem was 
added. Cells were then incubated in 5% CO2 at 34°C for 5 hours. After 5 hours 
the cotransfection mixture was replaced by DMEM supplemented with 6% FCS. 
After 60 hours the cells were scraped from the dish using a rubber policeman. 
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To harvest amplicon particles, three cycles of freezing-heating were performed 
using dry ice / Ethanol and a 37°C water bath before sonication for 10 sec with 
20% output. Cell debris was removed by centrifugation for 10 min at 1400 x g 
and the supernatant was stored at -80°C until further use.  
 
Table 2. Properties of two putative structural proteins of OvHV-2 and of fusion proteins 
derived thereof. 
 ORF43 ORF63 
OvHV-2 protein   
Identity (similarity) to 
AlHV-1 
 
83% (92%) 
 
61% (77%) 
Amino acids (aa) 562 947 
Predicted MW (kDa) 63.7 106.5 
Predicted localization  Capsid Tegument 
Fusion protein    
Construct N-GST-3C-43fragment-C N-GST-3C-63fragment-C 
OvHV-2-fragment (aa) H284-N434 (151) N833-L944 (111) 
Amino acids (fragments) 385 (234+151) 345 (234+111) 
Predicted MW 44.3 (27.2+17.1) 39.3 (27.2+12.1) 
Observed mobility (Mr) 50 (30+25) 43 (30+19) 
Amplicon-mediated   
Construct N-(eGFP)-ORF43-C N-(eGFP)-ORF63-C 
 
 
Immunization of rabbits and mice 
New Zealand White rabbits and C57BL/6 mice were immunized with purified 
fusion proteins. Preimmune sera were collected from all animals prior to the first 
vaccination. Purified fusion proteins were dialyzed against phosphate buffered 
saline (PBS) and mixed (1:1) with adjuvant before being applied. Freund's 
complete adjuvant (FCA) was used for the first immunization; Freund's 
incomplete adjuvant (FIA) for booster injections. Rabbits were immunized with 
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100 mg protein in a volume of 2 ml, mice with 20 mg protein in a volume of 100 
ml per injection. Rabbits received booster injections at monthly intervals, 
simultaneously with collection of serum samples. Mice received two 
immunizations at three week intervals. Mouse sera were collected two weeks 
after the second immunization and stored at -20°C until further use.  
 
Antisera, conjugates, and substrates 
In addition to the antisera described above, the following components were used: 
Mouse-anti-Vimentin (DAKO, Zug, Switzerland; code N1583); goat-anti-rabbit-
horseradish peroxidase (HRP) conjugate (Bioreba, Reinach, Switzerland); anti-
mouse-Envision (DAKO EnvisionTM System, horseradish peroxidase, Mouse; 
code K4001); DAKO EnvisionTM Doublestain System (code K1395); 
phosphatase conjugated anti-mouse-Envision (DAKO); Substrates: Aminoethyl 
Carbazole Substrate Kit (AEC-Kit, Stehelin AG, Basel, Switzerland). Fast red 
phosphatase chromogen solution (DAKO); goat-anti-rabbit serum conjugated 
with CyTM3 (Stehelin AG, Basel, Switzerland); chloronaphthol substrate solution 
with peroxide (4-chloro-1-naphtol tablets, Sigma, Buchs, Switzerland).  
 
Protease digestion, SDS-Polyacrylamide gel electrophoresis (PAGE), and 
immunoblotting 
To characterize the fusion proteins, GST was cleaved from the viral antigenic 
regions by digestion with human rhinovirus 3C protease (PreScission®, 
Amersham Pharmacia Biotech, Dübendorf, Switzerland). Loaded glutathione 
sepharose beads were washed with 10 x bed volume cleavage buffer containing 
50 mM Tris HCl pH 7.0, 150 mM NaCL, 1 mM EDTA, 1 mM DTT at 5°C 
before PreScission protease (80 units/ml) was added and incubated over night at 
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5°C. The beads with bound GST were then removed by centrifugation at 1800 x 
g for 10 minutes. 
Samples from different purification steps were mixed with SDS-loading buffer 
(62.5 mM Tris-HCl, pH 6.8, containing 25% glycerol, 2% sodium dodecyl 
sulfate, 0.01% bromphenol blue, 5% 2-mercaptoethanol; Bio-Rad Laboratories, 
AG, Reinach, Switzerland) and boiled for 10 min before being separated by 
SDS-PAGE containing 15% polyacrylamide and bisacrylamide (29:1) for 
crosslinking. After electrophoresis in Tris buffered (25 mM, pH 8.4) glycin (0.2 
M) and SDS (3.5 mM), the proteins were transferred electrically to nylon sheets 
(Hybond-P, Amersham Pharmacia). 
Immunoblotting was done at room temperature. The nitrocellulose membranes 
were blocked for 1 hour in PBS-A with 10% skim milk. Then, they were 
incubated for one hour with the rabbit sera of interest (each 1:1000 in PBS-A). 
After washing with PBS-A the blots were incubated for one hour with goat-anti-
rabbit-HRP conjugate (1:1000 in PBS-A). Finally, the reaction was visualized 
using a chloronaphthol substrate solution. 
 
Production and processing of pseudotissues 
Pseudotissues were produced using the Thermo Shandon CytoblockÒ Cell 
Preparation System (DAKO, Zug, Switzerland). Briefly, monolayers of Vero 2-2 
cells in Petri dishes (diameter of 6 cm) were transduced with packaged amplicon 
particles at an m.o.i. (multiplicity of infection) of 0.1. Transduction efficiency 
was monitored after 48 hours, either directly by fluorescence of eGFP or by 
immunofluorescence as described below.  
Cells were harvested by scraping into the supernatant with a rubber policeman, 
followed by centrifugation for 10 minutes at 1800 x g. The pellet was washed 
with PBS-A before being fixed for 1 hour at room temperature in phosphate 
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buffered (46 mM Na2HPO4 and 29 mM NaH2PO4, pH 7.0) 4 % formaldehyde. 
The pellet was then washed with 1% bovine serum albumine (BSA) solution in 
PBS before it was transferred to the Cytoblock Cell Preparation System and 
paraffin-embedded. The pellet was sectioned into 2 µm thin slices using a 
microtome (HM3555, Microm, Volketswil, Switzerland). The sections were 
mounted onto positive charged slides (SuperFrost Color, Menzel, Braunschweig, 
Germany) before being used in immunohistochemistry as described below.  
 
Infection of rabbits and harvesting of tissues 
Two New Zealand white rabbits were infected intravenously with cell-associated 
OvHV-2. One rabbit (MP02/1092) received 108 infected cattle T cells (BJ1035). 
The second rabbit (MP02/1445) received 108 infected rabbit T cells taken from 
BJ1035 passage 1. Rabbits were euthanized on day 16 (MP02/1445) and day 30 
(MP02/1092), when rectal temperatures had risen to >40°C for two days. 
Various tissues that are affected by OvHV-2 MCF were collected (appendix, 
lung, spleen, liver, mesenteric lymph nodes and kidney) and a portion of each 
tissue fixed in either 10% formal saline or zinc fixative (zinc salts consisting of 
0.1M tris base, 0.05% Ca acetate, 0.5% Zinc chloride and 0.5% Zinc acetate). 
The same tissues were taken from an uninfected control rabbit. Sections of 
rabbit tissue were mounted to slides as described above for pseudotissues. 
 
Immunofluorescence 
Incubations and washings were done at room temperature. Monolayers of 
transduced cells were fixed with methanol for 30 minutes before being incubated 
with the antisera of interest (diluted 1:1000 in PBS-A) for 1 hour. After washing 
with PBS-A, the Cy3-conjugate was overlaid for 1 hour. After further washing, 
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the cells were immediately observed using the fluorescent microscope. The 
FITC-filter (optimized for maximum emission at 507 nm) was used for the 
detection of eGFP-specific fluorescence, the DS-red filter (optimized for 
maximum emission at 583 nm) for Cy3.  
 
Immunohistology 
For immunohistochemistry slides, containing either rabbit tissue sections or 
pseudotissue sections, were deparaffinized on descending alcohol series and 
counter-stained with haemalaun for 3 minutes. All incubations and washings 
were done at room temperature. Endogenous peroxidase was blocked with water 
supplemented with 3% H2O2 and 0.2% NaN3 for 10 minutes. To minimize 
unspecific reactions, the slides were incubated for 10 minutes with DAKOÒ 
Protein Block Serum Free Solution (code X0909). The slides were washed with 
PBS before a pronase-treatment (code S2013, DAKOÒ) for 5 minutes was 
performed.  
After washing with PBS, the slides were incubated over night with 100 ml of 
primary antiserum at a dilution of 1:500. The next day the slides were washed 
and incubated for 30 minutes with the peroxidase conjugate, anti-mouse-
Envision. After further washing, the slides were developed for 10-15 minutes 
with amino-ethyl carbazole (AEC) substrate (Stehelin AG, Basel, Switzerland).  
The DAKO EnvisionTM Doublestain System (code K1395) was used to co-detect 
viral antigens (ORF 43 or 63 proteins) and vimentin with the following 
modification: to avoid unspecific staining of rabbit tissues with anti rabbit-
labelled polymers, an anti mouse polymer-horseradish peroxidase-conjugated 
antibody was used (code K4001, DAKO EnvisionTM ). The slides were treated as 
described above. After development of the anti-viral staining mouse-anti 43 or 
mouse-anti 63 with Diaminobenzidine (DAB) from the doublestain kit for 5 to 
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10 minutes, the slides were further incubated with DAKO® Double Staining 
block solution and DAKO® Protein Block Serum Free. Then, mouse-anti-
vimentin was added for 30 minutes. The secondary staining was developed by 
the alkaline phosphatase conjugated anti-mouse / anti-rabbit reagent from the 
doublestain kit, followed by visualization using the fast red chromogen solution 
for 5 to 10 minutes.  
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Results 
Identification of open reading frames encoding for potential OvHV-2 
structural proteins 
Nucleotide sequences from cosmid-cloned OvHV-2 DNA were compared with 
the DNA-sequence of Alcelaphine herpesvirus 1 (13) in order to identify 
putative structural proteins of OvHV-2. Among others, these analyses 
(summarized in Table 2) revealed two open reading frames (ORFs) whose 
predicted amino acid (aa) sequences were similar to those of a minor capsid 
protein (ORF43) and a tegument protein (ORF63), respectively, from AlHV-1.  
With 82% identity on the amino acid sequence level, the predicted OvHV-2 
ORF43 product was most closely related to its homolog in AlHV-1. Still 48% 
identity was found relative to the homologs in other gamma herpesviruses, i.e, 
BHV-4 and HHV-8. A marginal similarity of 22% was present even with the 
corresponding protein of the Bovine alpha herpesvirus 1 (BHV-1). The 
similarity of the ORF63 product to the homologs in other gamma herpesviruses 
ranged from 23% (HHV-8) to 18% (EBV) but the closest relation was again 
found with AlHV-1 (61.6% identity). Phylogenetic trees (Figure 1) showing the 
relations of these proteins with the corresponding proteins from other 
herpesviruses were calculated on the basis of the Clustal W algorithm for 
multiple alignment. 
Overall, the results concerning these two OvHV-2 proteins confirmed that 
OvHV-2 should be classified among the gamma herpesviruses. Furthermore, it 
may be expected that antisera against these two OvHV-2 proteins should be able 
to detect OvHV-2 in productively infected cells. 
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A 
 
 
B 
 
Figure 1. Dendrograms depicting the relationship between selected herpesviruses. The 
data are based on amino acid sequences of (A) ORF43 homologues and (B) ORF63 
homologues. Branch lengths are proportional to the distance between the respective 
sequences. The dendrogram was obtained using Clustal alignment from MegAlign 
(DNASTAR Programs package). 
 
Construction and expression of GST-fusion proteins containing OvHV-2-
specific fragments 
In order to generate antisera for the identification of these putative structural 
viral proteins, antigenic parts of the ORF43 and ORF63 encoded proteins were 
expressed as GST-fusion proteins (Table 2), purified as described in Materials 
and methods, and used for the immunization of rabbits and mice.  
The specificity of the resulting sera was tested on Western immunoblots (Figure 
2) using cleaved and uncleaved fusion proteins as antigens. The results indicated 
that both anti-ORF43 and anti-ORF63 sera recognized the GST-fragment in both 
of the uncleaved fusion proteins as well as the GST of a control preparation 
without viral antigenic region. In contrast, the band representing the cleaved 
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ORF43-region was stained only by the anti-ORF43 but not the anti-ORF63 
serum. Similarly, the cleaved ORF63-region was immune stained exclusively by 
the corresponding immune serum. These results indicated that both the rabbit 
sera (Figure 2) and the mouse sera (data not shown) specifically recognized the 
antigen that had been used for immunization.  
 
A            Anti-ORF43 serum B              Anti-ORF63 serum 
 
 
Figure 2. Characterization of fusion proteins and immune sera by Western 
immunoblots. The following samples were separated by SDS PAGE and blotted on 
nitrocellulose membranes: GST-tag alone (lanes 1), cleaved ORF63 fragment (lanes 2), 
ORF63 fusion protein (lanes 3), cleaved ORF43 fragment (lanes 4), ORF63 fusion protein 
(lanes 5), molecular weight marker (lanes 6). (A) immune-stained with anti-ORF43 serum, 
(B) with anti-ORF63 serum. Red arrows point to the specifically stained bands, representing 
the cleaved viral antigenic regions. Black arrows point to the location where the unrelated 
antigen is expected to migrate.  
 
Amplicon-mediated expression of full length ORF43 and ORF63 
Since productively OvHV-2 infected cell cultures were not available, ORF43 
and ORF63 were heterologously expressed in eukaryotic cells. The entire ORFs 
were cloned into HSV-1-based amplicon vectors, either alone or as fusion 
proteins with eGFP (Table 2). The amplicon vectors were packaged into HSV-1 
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particles, which then were used to transduce Vero 2-2 cells. Successfully 
transduced cells were identified by the expression of eGFP. Representative 
results are shown in Figure 3. Green fluorescence in the cytoplasm of cells was 
observed starting from 6 hours post transduction. At 48 hours, the time of 
maximal fluorescence, the cells were fixed and incubated with the rabbit 
immune sera followed by a Cy3 labelled conjugate. While the sera did not react 
with cells transduced with the unrelated construct, red fluorescence was 
observed in cells transduced with either one of the ORF43 amplicons and 
immune stained with the anti-ORF43 serum. Similarly, eukaryotically produced 
ORF63 protein was detected by the anti-ORF63 antiserum. Green and red 
fluorescence co-localized in cells transduced with the fusion proteins and stained 
with the corresponding antiserum. No differences in the immune reactivity of 
either fusionproteins or polypeptides without eGFP-tag were observed (not 
shown). 
These results indicated that the amplicon-mediated expression of OvHV-2 
ORF43 and ORF63 proteins was successful and that, in the absence of other 
viral proteins, these polypeptides accumulated in the cytoplasm of the 
transduced cells. The antisera, raised against prokaryotically expressed 
fragments of the same proteins, were able to recognize their targets in the native 
environment of the full-length proteins.  
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C  D 
  
Figure 3. Eukaryotic expression of ORF43 and ORF63.  VERO 2-2 cells transduced with 
an amplicon encoding for the eGFP-ORF43 (A+B) or eGFP-ORF63 (C+D) fusion proteins. 
Cells were observed under the fluorescence microscope using filters specific for eGFP (A+C) 
or Cy3 (B+D).  
 
To adapt immunohistological detection of OvHV-2 antigens to the use of 
formaldehyde-fixed and paraffin-embedded tissue, artificial tissues were 
prepared from a mixture of untransduced and transduced cells. For this purpose, 
monolayers of Vero 2-2 cells were transduced at a ratio of 10% with amplicons 
expressing the eGFP-fusion proteins. Green fluorescence served as indicator for 
the transduction ratio. 48 hours post transduction, the cells were trypsinized, 
pelleted, and placed into pre-formed gelatin-pockets to form a tissue-like body 
as described previously (9). Cell pellets were fixed with formalin and embedded 
in paraffin to simulate possible fixation of tissue samples. These pseudo-tissues 
were then sectioned and mounted. Between two and three cells per 104 retained 
fluorescent activity throughout this treatment. Thereafter, the slides were 
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incubated with antisera against ORF43 or ORF63 and conjugates as described in 
Materials and methods. Approximately the same number of cells that had 
retained fluorescent activity also reacted positively by immunohistology (Figure  
4). Apparently, a major amount of the proteins detected by immunohistology 
was present in the cytoplasm of the transduced cells.  
These results indicated that a loss in sensitivity amounting to a factor of 1'000 
had to be attributed to the procedures of fixation and embedding. Thus, the 
produced antisera could be expected to retain their ability to recognize their 
antigens, even in formalin-fixed and paraffin-embedded tissue.  
 
A B 
  
Figure 4. Detection of eukaryotically produced ORF43 and ORF63 proteins in 
formaldehyde-fixed pseudotissues.  Cells were transduced with an amplicon encoding for 
ORF43 (A) or ORF63 (B) and stained with anti-ORF43 serum or anti-ORF63 serum, 
respectively. Arrows point to positive cells. 
 
Detection of OvHV-2 protein in tissue of infected rabbits 
Recently, Rosbottom and others (2002) reported that rabbit T cell lines 
supported productive OvHV-2 replication. In addition, infectious material had 
been harvested from gut-associated lymphoid tissue such as mesenteric lymph 
nodes and appendix (37). It was hypothesized that structural viral proteins might 
be detected in such tissues of infected rabbits. When sections from tissues (see 
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Materials and methods) of OvHV-2-infected or non-infected rabbits were 
subjected to immunohistology with mouse antisera against the putative tegument 
protein 63, a specific staining was detected exclusively in sections from the 
appendix of OvHV-2-infected animals. A strong signal was visible in the basal 
portion of the top layer of the dome epithelium of infected (Figure 5B) but not 
uninfected rabbits (Figure 5A). The signal was absent when preimmune sera 
were used (Figure 5D). This staining pattern and the location of positive cells 
suggested that cells positive for OvHV-2 tegument protein 63 might be M-cells. 
Since vimentin is considered as a marker for rabbit M-cells (16,17), the same 
tissues from infected or uninfected rabbits were subjected to a consecutive 
staining with a monoclonal antibody against vimentin. While, tegument protein 
63 was not detected in tissue from uninfected rabbits, M-cells were stained in the 
same section (Figure 5C), essentially at the location, where viral protein had 
been observed in infected rabbits. In contrast, double positive staining was 
detected in appendices from infected rabbits, mostly at the periphery of the 
domes (Figure 5E,F). Thus, M-cells were identified as harboring structural 
protein of OvHV-2. Anti ORF43 antisera gave very similar staining patterns (not 
shown).  
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Figure 5. Detection of ORF63 protein in M-cells. Histological sections from the appendix 
of OvHV-2 infected (B,D,E,F) or uninfected (A,C) rabbits were subjected to 
immunohistology. Sections were stained with antiserum against tegument protein 63 (A+B) or 
double stained with the ORF63 serum and a monoclonal antibody against vimentin (C,E,F). 
(D) Section stained with pre-immune serum. Black arrow: ORF63 protein; red arrow: 
vimentin. Bars: 50 µm. 
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A second species of positive cells was identified as epithelial cells of the 
appendix. Figure 6 (A) shows a positive section of tissue from an OvHV-2-
infected rabbit labelled with anti-ORF43 serum. Anti-ORF63 serum gave very 
similar staining patterns (not shown). In contrast, tissues from uninfected rabbits 
revealed no immunostaining (Figure 6B). 
These results suggested that productive OvHV-2 infection in rabbits was 
ongoing in epithelial cells as well as in M-cells of the appendix. Simultaneously, 
the final link could be established between cosmid cloned OvHV-2 nucleotide 
sequences, antigens and antisera produced on this basis, and viral antigens in 
vivo. 
 
A B 
  
Figure 6. Detection of ORF43 protein in epithelial cells from OvHV-2-infected rabbits. 
Rabbits were inoculated with OvHV-2 and sacrificed upon appearance of MCF-like 
symptoms. Gut tissues from the appendix were treated for immunohistology with anti-ORF43 
serum as described in Materials and methods. (A) Positive epithelial cells with perinuclear 
cytoplasmic antigen. (B) Noninfected rabbit. 
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Discussion 
The main obstacle for better understanding the pathogenesis of sheep-associated 
malignant catarrhal fever is based on the lack of tools to study and trace the 
replication and biological properties of its causative agent, the ovine gamma 
herpesvirus type 2. Production and characterization of specific antibodies against 
this virus is still difficult because OvHV-2 cannot serially be propagated in cell 
cultures.  
To overcome these shortcomings, we took advantage of genomic nucleotide 
sequences, made available after cloning of the viral DNA into a cosmid library. 
Among the sequences of the first cosmid analyzed, two genes emerged encoding 
for potential structural proteins of OvHV-2, i.e. ORF43 and ORF63. 
Comparison of these ORFs with corresponding genes of other herpesviruses 
confirmed that OvHV-2 should be classified among the gamma herpesviruses 
and that AlHV-1 is a distinct but close relative (5). 
Fragments of these ORFs containing predicted antigenic portions of the encoded 
proteins were fused to the GST-gene, expressed in E. coli, and used to immunize 
rabbits and mice for the generation of specific antisera against these putative 
OvHV-2 structural proteins. Comparison of the amino acid sequence of the 
selected antigenic region of ORF43 with AlHV-1 revealed a high degree of 
similarity. Although not tested, the generation of potentially cross reacting 
antibodies in the immune sera can, therefore, not be excluded. In contrast, the 
antigenic region of ORF 63 shares only one stretch of 12 aa with the 
corresponding sequence of AlHV-1 ORF63. Therefore, crossreaction of these 
antisera with AlHV-1 is not likely.  
Our approach for generating antisera represents a standard procedure, which is 
often used to identify thus far unknown viral proteins (2,40). However, the 
difficulty in the present setting was that a cell culture-adapted strain of OvHV-2 
is not available for screening of the newly generated antisera. Therefore, the 
entire OvHV-2 ORFs were cloned independently into Herpes simplex type 1-
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based amplicon vectors to be expressed in eukaryotic cells, either alone or as 
fusion proteins with enhanced green fluorescent protein (eGFP)(38). These 
vectors were packaged into HSV-1 particles, which then were used to transduce 
Vero cells in order to eukaryotically express the OvHV-2 genes and use the 
transduced cells as a target for the newly raised antisera. Fluorescence from the 
eGFP-tags was used for controlling the transduction efficiency. Mixtures of 
transduced and non-transduced cells were used to form pseudo-organs, which 
could be sectioned in either a native or a fixed state, similar to conventional 
histopathological examinations. This approach represented an alternative to the 
generation of stably transformed cell lines, which express the desired antigens. It 
is well known that such cell lines sometimes are difficult to establish (43). Even 
if this task is done successfully, the problem of stable gene expression remains, 
not to speak of the production of sufficient amounts of the desired proteins 
within those cells. Since amplicon stocks can be titrated and used in a 
reproducible fashion, rendering the desired multiplicities of transduction, they 
bear also clear advantages over transient expression methods in eukaryotic cells 
by transfection or lipofection. Using these pseudo-organs in immunohistological 
experiments, it was possible to characterize the newly raised antisera with the 
aim to detect OvHV-2-antigen in tissues from infected animals.  
Finally, by means of immunohistology, tissues from infected and non-infected 
rabbits allowed to establish the link between replicating OvHV-2, i.e. 
productively infected cells, and cloned DNA sequences. Tissues found to 
contain OvHV-2-antigens by immunohistology revealed also the corresponding 
mRNAs as analyzed by Taqman-RT-PCR (data not shown). Moreover, M-cells 
as well as epithelial crypt cells in the appendix of the rabbits were identified as 
being productively infected with OvHV-2.  
 
Typically, only a subset of cells supports lytic replication by gamma 
herpesviruses. Tissues and blood cells obtained from diseased individuals rather 
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carry virus in various stages of latency (10,12,14,44). Therefore, only a minority 
of cells in the infected organism can be expected to carry antigen consisting of 
structural viral protein. However, accumulation of viral structural proteins can 
be expected in tissues predisposed for virus excretion. It was therefore not 
surprising that the majority of rabbit tissues reacted negatively with the newly 
developed antisera. Furthermore, a number of sheep tissues, previously tested 
positive for OvHV-2 DNA by quantitative fluorogenic PCR (20), did not react 
with these antisera (data not shown). Since infectious material had been 
harvested from gut-associated lymphoid tissue of OvHV-2-infected rabbits (39), 
mesenteric lymph nodes and appendices collected from such rabbits were likely 
to contain a certain number of lytically infected cells. Furthermore, the 
characteristic features of the predicted proteins chosen for detection makes it 
likely that they may be used as markers for lytic infection.  
According to its predicted amino acid sequence, the ORF43 protein is a homolog 
of herpes simplex virus type 1 (HSV-1) UL6. Its gene product is supposed to 
form the portal for entry of the viral DNA into preformed capsids (26). 
Therefore, detection of the ORF43 protein in rabbit M-cells and epithelial cells 
of the appendix, is indicative for the replicative state of OvHV-2 in these cells.  
The staining patterns found with the ORF63 proteins in our experiments 
resemble very much to the ones described for its homolog in HSV-2, the UL37 
protein. In HSV-2-infected cells, the UL37 protein accumulates as a punctate 
structure in the perinuclear region, whereas it is mainly found in the cytoplasm 
of transfected cells without ongoing viral replication (48). Considering that the 
ORF63 protein of OvHV-2 may behave in a similar way, its punctate to diffuse 
intracytoplasmic pattern in rabbit M-cells argues for ongoing replication of 
OvHV-2. In contrast, the UL37 protein of HSV-1 is diffusely distributed in the 
cell but more abundant in the cytoplasm than in the nucleus and constitutes a 
minor tegument protein (11). Yet, the UL37 product of HSV-1 is synthesized 
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late in infection (gamma 1 protein), which also supports its usefulness as a 
marker for lytic replication (36).  
 
M-cells are specialized epithelial cells, located in the lymphoid tissue of the gut, 
including Peyer's patches, and capable of antigen presentation 
(4,21,27,35,39,46). They are thought to take up antigens from the intestinal 
lumen in order to present them directly to lymphocytes within the patch. 
Interestingly, antigens that enter M-cells are likely to not be degraded but rather 
passed on to other cells or to the intercellular space. Indeed, soluble 
macromolecules, small particles, and even whole organisms are transported by 
M-cells. Therefore, some pathogens, such as salmonellae, Yersinia, Listeria, and 
reoviruses can use M-cells as a portal to enter the body. Since intravenous 
inoculation of OvHV-2 had been used for infection of rabbits, it is unlikely that 
this pathway actually played a role under our experimental conditions. Yet, M-
cells interact closely with lymphocytes, which may harbor the OvHV-2 genome. 
Periods of interaction between the two cell types may then lead to reactivation of 
OvHV-2 from latency, which would eventually result in the synthesis and 
accumulation of structural viral proteins in M-cells. Under these conditions, it 
seems to be logical that we were able to detect structural OvHV-2 antigens in M-
cells as well as in epithelial cell in their vicinity.  
Moreover, since antigen presenting cells play an important role in the initiation 
and quality of the adaptive immune response, the infection of M-cells may bring 
some dramatic consequences with it. For example OvHV-2 encodes for an IL-10 
homolog (J. Rosbottom, G. Jayawardane, J. Stewart, H. Reid, and M. 
Ackermann, manuscript in preparation), which might be able to deviate the 
developing immune response in a fashion that is specific for the infected host 
species. Since sheep but not cattle or swine underwent co-evolution with OvHV-
2, this may ultimately explain why the pathogenesis of the OvHV-2 infection 
proceeds differently in various animal species.  
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In conclusion, antisera raised against two predicted structural proteins of OvHV-
2 were able to establish a link between cloned viral DNA and antigens present in 
tissues of diseased animals. Since these tissues also contain infectivity, it is most 
likely that these antisera actually recognize lytically infected cells. The data 
gained in this study shed light on new aspects to understanding the pathogenesis 
of MCF in various animal species.
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